Who we are

 

We are a team of strategy consultants based in London (UK). We work and travel globally to support our clients, in Europe, the US and emerging markets, among other places.

We build insight into our clients’ challenges and objectives through close engagement with them and their stakeholders. Rigorous analysis and structured presentations then become the foundation of our recommendations.

iStock-947467630.jpg

Our team

AB.jpg

Andrew Bell

Managing Director

Andrew is the founder and Managing Director of Strategy in Life Sciences (SiLS). In nearly twenty years of consulting he has worked with a wide range of life science companies on their critical business strategy issues, including corporate and functional strategy development, performance improvement and the development and implementation of decision analytics approaches.

Prior to establishing SiLS, Andrew worked at AVOS Consulting (Syneos Health), Charles River Associates, IMS Consulting (IQVIA) and L.E.K. Consulting.

Andrew holds a DPhil (Organic Chemistry) and a BA (Chemistry) from the University of Oxford.

 
DN.png

Daniel Naujoks

Engagement Manager

Daniel has built strong relationships with leading pharma and life science companies through projects ranging from functional strategy to change management and complex modelling.

His previous work at AVOS Consulting, Roland Berger and L.E.K. covered due diligence, product strategy, business planning and operational topics.

Daniel holds a PhD (Molecular Genetics) from Imperial College, London and a BA (Natural Sciences) from the University of Cambridge.

 
pedrojoaofigueiredoaparicio54_highres_2.jpg

Pedro Aparício

Associate

Pedro’s career has focused on working with companies and end-users across a variety of sectors to develop and implement innovative technology, in particular digital and analytical tools.

Before joining SiLS, Pedro worked at A.T. Kearney and SEHTA, where he gained experience on digital transformation, process re-design, technology development and market introduction in the sectors of healthcare, utilities, process industries.

Pedro holds a PhD (Computational Biology) and an MSc (Biomedical Engineering) from the University of Oxford.